locally advanced head and neck squamous cell carcinoma
Showing 1 - 20 of 20
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (volrustomig)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
-
Prescott Valley, Arizona
- +71 more
Nov 10, 2023
TPExtreme Induced Chemotherapy Followed by Surgery and
Recruiting
- Oral Squamous Cell Carcinoma
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Modified radical surgery
- Radical surgery
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
May 14, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Toripalimab
- Stereotactic Body Radiation Therapy (SBRT)
-
Tianjin, China
- +1 more
May 16, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- (no location specified)
Mar 20, 2023
Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +2 more
- RP3
- +3 more
- (no location specified)
Feb 21, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Xevinapant, Placebo)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Xevinapant
- Placebo
- (no location specified)
Feb 10, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Columbus (Counseling, Dietary Counseling and Surveillance,
Active, not recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Counseling
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jan 5, 2023
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Cemiplimab
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 6, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Hamilton, London, Toronto (High-Dose Cisplatin, Low-Dose
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- High-Dose Cisplatin
- +2 more
-
Hamilton, Ontario, Canada
- +2 more
Jun 7, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (NBTXR3, Cetuximab, Radiation Therapy)
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- NBTXR3
- +2 more
-
Tampa, Florida
- +17 more
Mar 22, 2022
Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
-
Beijing, Beijing, China
- +4 more
Mar 3, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +5 more
- Tolinapant
- Radiation Therapy
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 17, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck
Recruiting
- Advanced Head and Neck Squamous Cell Carcinoma
- +5 more
- Pembrolizumab (immunotherapy)
- Quad-shot palliative radiotherapy
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Feb 7, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Zhuhai (PD-1 inhibitor+ Gemcitabine +
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Neoadjuvant Therapy
- PD-1 inhibitor+ Gemcitabine + Cisplatin
-
Zhuhai, Guangdong, ChinaFifth Affilliated Hospital of Sun Yat-sen University
Jun 23, 2021
Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, Locally
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- +18 more
- Proton Beam Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 30, 2021
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Seoul (genexolPM + cisplatin)
Completed
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- genexolPM + cisplatin
-
Seoul, Korea, Republic of
- +1 more
Dec 4, 2020
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Guiyang (Lobaplatin, Cisplatin)
Unknown status
- Locally Advanced Head and Neck Squamous Cell Carcinoma
-
Guiyang, Guizhou, ChinaCancer Hospital of Guizhou Medical University
Apr 14, 2017